These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 29792689)

  • 1. Selectivity within a Family of Bacterial Phosphothreonine Lyases.
    Chambers KA; Abularrage NS; Scheck RA
    Biochemistry; 2018 Jul; 57(26):3790-3796. PubMed ID: 29792689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Michael addition of dehydroalanine-containing MAPK peptides to catalytic lysine inhibits the activity of phosphothreonine lyase.
    Zhang Y; Yang R; Huang J; Liang Q; Guo Y; Bian W; Luo L; Li H
    FEBS Lett; 2015 Nov; 589(23):3648-53. PubMed ID: 26519561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eliminylation: a post-translational modification catalyzed by phosphothreonine lyases.
    Brennan DF; Barford D
    Trends Biochem Sci; 2009 Mar; 34(3):108-14. PubMed ID: 19233656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural insights into the enzymatic mechanism of the pathogenic MAPK phosphothreonine lyase.
    Zhu Y; Li H; Long C; Hu L; Xu H; Liu L; Chen S; Wang DC; Shao F
    Mol Cell; 2007 Dec; 28(5):899-913. PubMed ID: 18060821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for the catalytic mechanism of phosphothreonine lyase.
    Chen L; Wang H; Zhang J; Gu L; Huang N; Zhou JM; Chai J
    Nat Struct Mol Biol; 2008 Jan; 15(1):101-2. PubMed ID: 18084305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide search for eliminylating domains reveals novel function for BLES03-like proteins.
    Khater S; Mohanty D
    Genome Biol Evol; 2014 Jul; 6(8):2017-33. PubMed ID: 25062915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient Enzymatic Incorporation of Dehydroalanine Based on SAMDI-Assisted Identification of Optimized Tags for OspF/SpvC.
    Yang A; Tao H; Szymczak LC; Lin L; Song J; Wang Y; Bai S; Modica J; Huang SY; Mrksich M; Feng X
    ACS Chem Biol; 2022 Feb; 17(2):414-425. PubMed ID: 35129954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Chemical Probe for Dehydrobutyrine.
    Chambers KA; Abularrage NS; Hill CJ; Khan IH; Scheck RA
    Angew Chem Int Ed Engl; 2020 May; 59(19):7350-7355. PubMed ID: 32196905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SpvC is a Salmonella effector with phosphothreonine lyase activity on host mitogen-activated protein kinases.
    Mazurkiewicz P; Thomas J; Thompson JA; Liu M; Arbibe L; Sansonetti P; Holden DW
    Mol Microbiol; 2008 Mar; 67(6):1371-83. PubMed ID: 18284579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of GSK3beta reveals a primed phosphorylation mechanism.
    ter Haar E; Coll JT; Austen DA; Hsiao HM; Swenson L; Jain J
    Nat Struct Biol; 2001 Jul; 8(7):593-6. PubMed ID: 11427888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The phosphothreonine lyase activity of a bacterial type III effector family.
    Li H; Xu H; Zhou Y; Zhang J; Long C; Li S; Chen S; Zhou JM; Shao F
    Science; 2007 Feb; 315(5814):1000-3. PubMed ID: 17303758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salmonella type III effector SpvC, a phosphothreonine lyase, contributes to reduction in inflammatory response during intestinal phase of infection.
    Haneda T; Ishii Y; Shimizu H; Ohshima K; Iida N; Danbara H; Okada N
    Cell Microbiol; 2012 Apr; 14(4):485-99. PubMed ID: 22188134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphothreonine Lyase Promotes p65 Degradation in a Mitogen-Activated Protein Kinase/Mitogen- and Stress-Activated Protein Kinase 1-Dependent Manner.
    Hou M; Wang W; Hu F; Zhang Y; Yang D; Liu Q
    Infect Immun; 2019 Jan; 87(1):. PubMed ID: 30396897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new approach to phosphoserine and phosphothreonine analysis in peptides and proteins: chemical modification, enrichment via solid-phase reversible binding, and analysis by mass spectrometry.
    Thaler F; Valsasina B; Baldi R; Xie J; Stewart A; Isacchi A; Kalisz HM; Rusconi L
    Anal Bioanal Chem; 2003 Jun; 376(3):366-73. PubMed ID: 12734628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence of free O-phosphoserine and O-phosphothreonine in porcine liver.
    Kataoka H; Sakiyama N; Makita M
    Agric Biol Chem; 1990 Jul; 54(7):1731-3. PubMed ID: 1368590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of protein kinase-C inhibition on insulin receptor phosphorylation.
    Duronio V; Jacobs S
    Endocrinology; 1990 Jul; 127(1):481-7. PubMed ID: 2193799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shigella flexneri type III secreted effector OspF reveals new crosstalks of proinflammatory signaling pathways during bacterial infection.
    Reiterer V; Grossniklaus L; Tschon T; Kasper CA; Sorg I; Arrieumerlou C
    Cell Signal; 2011 Jul; 23(7):1188-96. PubMed ID: 21402152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic insights into the multistage gas-phase fragmentation behavior of phosphoserine- and phosphothreonine-containing peptides.
    Palumbo AM; Tepe JJ; Reid GE
    J Proteome Res; 2008 Feb; 7(2):771-9. PubMed ID: 18181561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-free detection of phosphoserine/threonine containing peptides by homogeneous time-resolved fluorescence.
    Alpha-Bazin B; Quéméneur E
    Anal Chem; 2012 Nov; 84(22):9963-70. PubMed ID: 23110758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational investigation of the enzymatic mechanisms of phosphothreonine lyase.
    Pei Q; Christofferson A; Zhang H; Chai J; Huang N
    Biophys Chem; 2011 Aug; 157(1-3):16-23. PubMed ID: 21558045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.